SEC Form 3 · accession 0001731122-19-000076
Enochian Biosciences Inc · ENOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Luisa Puche
Officer — Chief Financial Officer
Period of report
Jan 7, 2019
Accepted (ET)
Feb 28, 2019 · 1:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001527728
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Ms. Puche was appointed as Chief Financial Officer of Enochian Biosciences, Inc. on January 7, 2019.